½ÃÀ庸°í¼­
»óǰÄÚµå
1642866

HCS/I(High Content Screening/Imaging) : °¢Á¾ ±â¼ú°ú ¼¼°è ½ÃÀå

High Content Screening/Imaging: Technologies and Global Markets

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 141 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è HCS/I(High Content Screening/Imaging) ½ÃÀå ±Ô¸ð´Â 2024³â 34¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 8.4%ÀÇ CAGR·Î 2029³â¿¡´Â 51¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀº 2024³â 12¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 7.1%·Î ¼ºÀåÇÏ¿© 2029³â¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2024³â 8¾ï 8,670¸¸ ´Þ·¯¿¡¼­ ¿¬Æò±Õ 9.5%(CAGR 9.5%)·Î ¼ºÀåÇÏ¿© 2029³â¿¡´Â 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ HCS/I(High Content Screening/Imaging) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±ÔÁ¦ ȯ°æ, ½Å±â¼ú ¹× ±â¼ú °³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • Á¶»ç ¹üÀ§
  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • HCS(High Content Screening) ±â¼ú °³¿ä
  • HTS(High Throughput Screening)
  • High Throughput Screening ÇÁ·Î¼¼½º
  • HTS ¹ßÀü

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • °³¿ä
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ¿¬±¸°³¹ß ¿¹»ê Áõ°¡
  • HCS/IÀÇ ±â¼ú Áøº¸
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • ³ôÀº ¼³ºñ ºñ¿ë
  • µ¥ÀÌÅÍ °ü¸® °úÁ¦
  • ½ÃÀåÀÇ ±âȸ
  • 3D ¿ëµµ¿¡¼­ ±âȸ
  • ½ÅÈï °æÁ¦±¹

Á¦4Àå ½Å±â¼ú°ú °³¹ß

  • °³¿ä
  • ½Å±â¼ú
  • ÇÏÀÌ ÄÁÅÙÃ÷ À̹ÌÁö ºÐ¼®À» À§ÇÑ AI
  • ¼¿ ÆäÀÎÆÃ
  • 3D ¿À°¡³ëÀ̵å, Á¾¾çÀ¯»çü, ±¸Çüü ¹è¾ç

Á¦5Àå ½ÃÀå ºÎ¹® ºÐ¼®

  • ¼¼ºÐÈ­ ³»¿ª
  • ½ÃÀå ºÐ¼® : ±¸¼º¿ä¼Òº°
  • ±â±â
  • ¼Ò¸ðǰ
  • ¼ÒÇÁÆ®¿þ¾î¿Í ºÐ¼®
  • ¼­ºñ½º
  • ½ÃÀå ºÐ¼® : ¿ëµµº°
  • 1Â÷ ½ºÅ©¸®´×°ú 2Â÷ ½ºÅ©¸®´×
  • Ÿ°Ù ½Äº°°ú °ËÁõ
  • È­ÇÕ¹° ÇÁ·ÎÆÄÀϸµ
  • µ¶¼º ¿¬±¸
  • ±âŸ
  • ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • Á¦¾àȸ»ç
  • Çмú±â°ü
  • ½ÇÇè½Ç ¹× º´¸®ÇÐ ¼¾ÅÍ
  • Áö¿ªÀû ³»¿ª
  • ½ÃÀå ºÐ¼® : Áö¿ªº°
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦6Àå °æÀï Á¤º¸

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • Àü·« ºÐ¼®
  • ÆÄÆ®³Ê½Ê
  • M&A
  • Á¦Ç° ¹ß¸Å
  • °¡°Ý ºÐ¼®

Á¦7Àå Æ¯Çã ¸®ºä

  • ƯÇã ¸®ºä
  • ƯÇã ¸®ºä : ¿¬µµº°
  • ƯÇã ¸®ºä : °üÇÒº°
  • ƯÇã ¸®ºä : ÁÖ¿ä Ãâ¿øÀκ°
  • ÁÖ¿ä Æ¯Çã

Á¦8Àå HCS/I ½ÃÀåÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

  • ESGÀÇ °üÁ¡
  • ȯ°æ¿¡ ´ëÇÑ ¿µÇâ
  • »çȸÀû ¿µÇâ
  • °Å¹ö³Í½ºÀÇ ¿µÇâ
  • ESG µ¥ÀÌÅÍ ÀÌÇØ
  • ESG ÆÛÆ÷¸Õ½º ºÐ¼®
  • ȯ°æ ÆÛÆ÷¸Õ½º
  • »çȸÀû ÆÛÆ÷¸Õ½º
  • °Å¹ö³Í½º ÆÛÆ÷¸Õ½º
  • BCC¿¡ ÀÇÇÑ °á·Ð

Á¦9Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¤º¸ Ãâó
  • ¾à¾î
  • ±â¾÷ °³¿ä
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CHARLES RIVER LABORATORIES
  • CORNING INC.
  • DANAHER CORP.
  • EVIDENT
  • MERCK KGAA
  • MILTENYI BIOTEC
  • REVVITY
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.
  • YOKOGAWA ELECTRIC CORP.
  • ZEISS
ksm 25.02.26

The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.

The North American market for HCS/I is estimated to increase from $1.2 billion in 2024 to reach $1.8 billion by 2029, at a CAGR of 7.1% from 2024 through 2029.

The Asia-Pacific market for HCS/I is estimated to increase from $886.7 million in 2024 to reach $1.4 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.

Report Scope

The report offers a detailed picture of the high-content screening/imaging (HCS/I) market.

This report highlights the current and future market potential for HCS/I. It provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2029 and the market share of key players.

This report discusses the HCS/I industry and its resources. It covers the overall HCS/I market including instruments, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, analyzing primary and secondary screening, target identification and validation, compound profiling, and toxicity studies. A complete regional analysis of the market is also offered in the report.

The market is segmented by region into North America, Europe, Asia-Pacific and the Rest of the World. Regional analysis is further broken down by country. North America is segmented into the U.S., Canada and Mexico; Europe is segmented into Germany, the U.K., France, Italy, Spain and the Rest of Europe; and Asia-Pacific is segmented into China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2024 through 2029.

Report Includes

  • 56 data tables and 57 additional tables
  • Analyses of the trends in global market for high content screening/imaging (HCS/I) technologies, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects, along with a market share analysis by component, area of application, end user and region/country
  • Facts and figures pertaining to key market dynamics, technological advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
  • An analysis of patents, emerging trends and developments
  • A pricing analysis for HCS/I instruments from leading companies
  • Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activities, and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Company profiles of major players within the industry, including Danaher Corp., Revvity, Thermo Fischer Scientific Inc., Agilent Technologies Inc., and Yokogawa Electric Corp.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Insights

Chapter 2 Market Overview

  • High-Content Screening Technology Overview
  • High-Throughput Screening (HTS)
  • Process Involved in High-Throughput Screening
  • Developments in HTS

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Increasing R&D Budgets
  • Technological Advances in HCS/I
  • Market Restraints and Challenges
  • High Equipment Costs
  • Data Management Challenges
  • Opportunities in the Market
  • Opportunities in 3D Applications
  • Emerging Economies

Chapter 4 Emerging Technologies and Developments

  • Overview
  • Emerging Technologies
  • AI for High-Content Image Analysis
  • Cell Painting
  • 3D Organoid, Tumoroid and Spheroid Cultures

Chapter 5 Market Segment Analysis

  • Segmentation Breakdown
  • Market Analysis by Component
  • Instruments
  • Consumables
  • Software and Analytics
  • Services
  • Market Analysis by Application
  • Primary and Secondary Screening
  • Target Identification and Validation
  • Compound Profiling
  • Toxicity Studies
  • Other Applications
  • Market Analysis by End User
  • Pharmaceutical Companies
  • Academics
  • Laboratories and Pathology Centers
  • Geographic Breakdown
  • Market Analysis by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of Asia-Pacific
  • Rest of the World (RoW)

Chapter 6 Competitive Intelligence

  • Company Share Analysis
  • Strategic Analysis
  • Partnerships
  • Mergers and Acquisitions
  • Product Launches
  • Pricing Analysis

Chapter 7 Patent Review

  • Patent Review
  • Patent Review by Year
  • Patent Review by Jurisdiction
  • Patent Review by Top Applicants
  • Selected Granted Patents

Chapter 8 Sustainability in the HCS/I Market: An ESG Perspective

  • ESG Perspective
  • Environmental Impact
  • Social Impact
  • Governance Impact
  • Understanding the ESG Data
  • ESG Performance Analysis
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC

Chapter 9 Appendix

  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CHARLES RIVER LABORATORIES
  • CORNING INC.
  • DANAHER CORP.
  • EVIDENT
  • MERCK KGAA
  • MILTENYI BIOTEC
  • REVVITY
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.
  • YOKOGAWA ELECTRIC CORP.
  • ZEISS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦